Between February 23 and 24, Johan Lannebo, through the company Zubizuri, acquired 50,000 shares in the life science investment company Linc, where he serves as a board member. The shares were bought at an average price of 66.07 kronor per share, amounting to a transaction worth 3.3 million kronor. The deal was executed on Nasdaq Stockholm. This information is disclosed in the Swedish Financial Supervisory Authority's insider register.

Following this transaction, Johan Lannebo now holds 300,000 shares in Linc, according to the shareholder service Holdings.